[50th Annual Meeting of the American Academy of Neurology (AAN). Minneapolis, 25 April--2 May 1998. 151st Annual Meeting of the American Psychiatric Association (APA). Toronto, 31 May--3 June 1998].
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D003704:Dementia / Q000175:diagnosis; D003937:Diagnosis, Differential; D000077265:Donepezil; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D009462:Neurology; D018697:Nootropic Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis; D010880:Piperidines / Q000627:therapeutic use; D011570:Psychiatry; D012955:Societies, Medical
D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil
50th Annual Meeting of the American Academy of Neurology (AAN) Minneapolis, 25. April bis 2. Mai 1998. 151st Annual Meeting of the American Psychiatric Association (APA) Toronto, 31. Mai bis 3. Juni 1998.